Suppr超能文献

来自印度北部的首个遗传性面肩肱型肌营养不良症的基因确认队列。

The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India.

机构信息

Department of Neurology, All India Institute of Medical Sciences (AIIMS), Delhi, India.

Department of Human Genetics, Leiden University Medical Center (LUMC), Leiden, The Netherlands.

出版信息

Eur J Hum Genet. 2024 Sep;32(9):1053-1064. doi: 10.1038/s41431-024-01577-z. Epub 2024 Apr 25.

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common form of hereditary myopathy. Sixty per cent of the world's population lives in Asia, so a significant percentage of the world's FSHD participants is expected to live there. To date, most FSHD studies have involved individuals of European descent, yet small-scale studies of East-Asian populations suggest that the likelihood of developing FSHD may vary. Here, we present the first genetically confirmed FSHD cohort of Indian ancestry, which suggests a pathogenic FSHD1 allele size distribution intermediate between European and North-East Asian populations and more asymptomatic carriers of 4 unit and 5 unit FSHD1 alleles than observed in European populations. Our data provides important evidence of differences relevant to clinical diagnostics and underscores the need for global FSHD participation in research and trial-ready Indian FSHD cohorts.

摘要

面肩肱型肌营养不良症(FSHD)是第三常见的遗传性肌病。全球有 60%的人口生活在亚洲,因此预计全球 FSHD 参与者中有相当大的比例生活在亚洲。迄今为止,大多数 FSHD 研究都涉及欧洲血统的个体,然而对东亚人群的小规模研究表明,发生 FSHD 的可能性可能有所不同。在这里,我们展示了第一个具有遗传确认的印度血统的 FSHD 队列,该队列表明致病性 FSHD1 等位基因大小分布介于欧洲和东北亚人群之间,并且具有 4 个单位和 5 个单位 FSHD1 等位基因的无症状携带者比在欧洲人群中观察到的更多。我们的数据提供了与临床诊断相关的重要差异的证据,并强调了在研究和试验准备就绪的印度 FSHD 队列中需要全球 FSHD 参与的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b3/11368952/49d0fecb6638/41431_2024_1577_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验